166737-85-5Relevant articles and documents
Synthesis method of S-trityl-L-cysteinamide
-
Paragraph 0007; 0013; 0015-0019, (2021/08/07)
The invention relates to a synthesis method of S-trityl-L-cysteinamide. The method mainly solves the technical problem of product racemization in the existing synthesis method. The preparation method comprises the following three steps: step 1, adding CDI into a tetrahydrofuran solution of (+)-S-trityl-L-cysteine, stirring to react for 4 hours, and adding ammonia water to obtain a compound 1; 2, the compound 1 reacts with piperidine in N, N-dimethylformamide to obtain a compound 2; and 3, dissolving the compound 2 in ethyl acetate, adding L-dibenzoyl tartaric acid to form salt, measuring that ee is greater than 99.0%, and alkalifying to obtain a pure compound 3.
Aminothiol compound, preparation method of aminothiol compound and application of aminothiol compound in radiation protection
-
, (2017/04/03)
The invention discloses an aminothiol compound, a preparation method of the aminothiol compound and application of the aminothiol compound in radiation protection. The compound has a structure shown in the formula I in the description, wherein A1 is selected from -C(O)NR8-, -S(O)2-NR8-, -S(O)NR8- and -R7-NR8-, A2 is selected from carbonyl, sulfonyl, sulfinyl and substituted or unsubstituted C1-6 alkyl, R1, R2, R5 and R6 can be the same or not and are selected from hydrogen and substituted or unsubstituted C1-C5 alkyl or hetero alkyl, n is an integer from 0 to 20000, R3 and R4 are independently selected from hydrogen, X and substituted or unsubstituted C1-6 alkyl, X is selected from F, Cl, Br and I, R7 is selected from substituted or unsubstituted C1-C6 alkyl, and R8 is selected from hydrogen and substituted or unsubstituted C1-C6 alkyl. The compound has the effect of reducing biological injury caused by ionizing radiation and also has the effects of prolonging the lifetime of radiated animals and increasing the survival rate of the radiated animals.
ACETYLENIC SULFONAMIDE THIOL TACE INHIBITORS
-
Page 23, (2008/06/13)
Compounds of formula (B): (1a), or (1b), (1c) are provided wherein the variables are as defined herein which are useful in disease conditions mediated by TNF- alpha , such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple